FXP Performance — ProShares UltraShort FTSE China 50
Data updated: 2026-08-14
FXP returned +17.03% year to date and −7.48% over one year to May 2026. Annualised returns are −32.15% over 3 years and −16.51% over 5 years. The fund trailed its Trading - Leveraged category average: $100 invested three years ago grew to $31, against $173 for the category, and to $93 over one year, against $137. Volatility over the past three years was 39.19% a year. In the 12 months to May 2026 the fund took in a net $35K, and assets reached $6.31M.
FXP Growth of $100
What $100 invested in ProShares UltraShort FTSE China 50 grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Trading - Leveraged category average over the same months.
| Period | FXP | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $93 | $137 |
| 3 years (Jun 2023 – May 2026) | $31 | $173 |
| 5 years (Jun 2021 – May 2026) | $41 | $155 |
| Since data start (Sep 2019 – May 2026) | $17 | $181 |
FXP Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +17.03% |
| 1 year | −7.48% |
| 3 years (annualised) | −32.15% |
| 5 years (annualised) | −16.51% |
FXP Annual Returns
Calendar-year total returns of ProShares UltraShort FTSE China 50, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | +17.03% |
| 2025 | −45.42% |
| 2024 | −52.30% |
| 2023 | +12.77% |
| 2022 | −11.90% |
| 2021 | +23.48% |
| 2020 | −39.53% |
| 2019 (Sep–Dec) | −23.68% |
FXP Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −7.3% | +12.7% | +7.0% | −4.7% | +9.8% | — | — | — | — | — | — | — |
| 2025 | −9.4% | −19.0% | −4.7% | +6.0% | −6.8% | −12.0% | −3.3% | −7.6% | −10.5% | +6.3% | +1.0% | +4.6% |
| 2024 | +20.0% | −15.5% | −5.7% | −11.3% | −9.9% | +4.2% | +2.2% | −5.7% | −34.3% | −5.0% | +5.9% | −6.1% |
| 2023 | −22.7% | +27.9% | −12.0% | +7.9% | +17.1% | −10.7% | −21.6% | +21.8% | +6.2% | +7.3% | +2.0% | +3.4% |
| 2022 | −9.6% | +16.7% | −5.4% | +3.1% | −9.7% | −15.5% | +22.5% | −0.3% | +34.3% | +43.6% | −48.6% | −7.3% |
| 2021 | −13.5% | −0.5% | +7.3% | +0.7% | −0.8% | −2.2% | +25.7% | −3.9% | +8.5% | −8.5% | +9.4% | +4.4% |
| 2020 | +18.3% | −5.4% | +3.3% | −8.0% | −4.6% | −6.3% | −12.3% | −12.4% | +8.3% | −10.2% | −13.6% | −1.3% |
| 2019 | — | — | — | — | — | — | — | — | −3.7% | −6.7% | +0.5% | −15.4% |
FXP Risk
Risk measures from monthly returns over Jun 2023 – May 2026.
- 3-year volatility (annualised): 39.19%
- 3-year Sharpe ratio: -0.94 (vs 4.5% risk-free rate)
- Best month: +21.80% (Aug 2023)
- Worst month: −34.28% (Sep 2024)
FXP Fund Flows
Monthly money in and out of ProShares UltraShort FTSE China 50, from SEC Form N-PORT.
- 12-month net flow: $35K
- 12-month gross sales (incl. reinvestments): $2.8M
- Sales ÷ redemptions: 1.01×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $190K | $0 | $190K |
| Apr 2026 | $0 | $1.2M | −$1.2M |
| Mar 2026 | $393K | $210K | $184K |
| Feb 2026 | $524K | $9 | $524K |
| Jan 2026 | $0 | $852K | −$852K |
| Dec 2025 | $0 | $182K | −$182K |
| Nov 2025 | $0 | $0 | $0 |
| Oct 2025 | $408K | $0 | $408K |
| Sep 2025 | $174K | $0 | $174K |
| Aug 2025 | $697K | $0 | $697K |
| Jul 2025 | $400K | $324K | $75K |
| Jun 2025 | $0 | $0 | $0 |
FXP Assets Under Management
Net assets of ProShares UltraShort FTSE China 50 by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $6.31M |
| 2026-02-28 | $6.43M |
| 2025-11-30 | $6.47M |
| 2025-08-31 | $6.18M |
| 2025-05-31 | $7.01M |
| 2025-02-28 | $8.03M |
| 2024-11-30 | $11.50M |
| 2024-08-31 | $14.97M |
| 2024-05-31 | $14.97M |
| 2024-02-29 | $17.93M |
| 2023-11-30 | $21.04M |
| 2023-08-31 | $21.50M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.